Drug intelligence / Profile preview

EFF1009

Development stage: Unknown
Lead developer: Everfront Biotech
Modality: Small Molecules
Administration: Oral

Overview

EFF1009 is a medical food emulsion developed by Efficas for the dietary management of asthma. It consists of a specific combination of the omega-6 fatty acid gamma-linolenic acid (GLA) and the omega-3 fatty acid eicosapentaenoic acid (EPA). The product is designed to modulate the inflammatory response in asthmatic patients by inhibiting the synthesis of pro-inflammatory leukotrienes, specifically leukotriene B4 (LTB4). Clinical studies have demonstrated that EFF1009 can improve asthma-related quality of life (ARQOL) and reduce asthma symptoms when used as an adjunct to standard asthma medications. It acts by providing alternative fatty acid substrates that compete with arachidonic acid in the 5-lipoxygenase pathway.

Brand names: Efficas Care
Other names: gamma-linolenic acid + eicosapentaenoic acidGLA + EPA emulsion

Targets

ALOX5 (Arachidonate 5-lipoxygenase)

Beyond the preview

Go deeper on EFF1009.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on EFF1009.

Explore the full profile